...
首页> 外文期刊>European journal of pharmaceutical sciences >Application of multiple stepwise spinning disk processing for the synthesis of poly(methyl acrylates) coated chitosan-diclofenac sodium nanoparticles for colonic drug delivery
【24h】

Application of multiple stepwise spinning disk processing for the synthesis of poly(methyl acrylates) coated chitosan-diclofenac sodium nanoparticles for colonic drug delivery

机译:多阶梯式旋转盘加工在聚(甲基丙烯酸甲酯)涂布的壳聚糖 - 二氯芬酸钠纳米粒子结肠药物递送中的应用

获取原文
获取原文并翻译 | 示例

摘要

The production of pharmaceutical nanoparticles by the spinning disk processing (SDP) technique has advantages in terms of its scalability and its capacity to produce readily tunable nanoparticles of narrow size distribution. In this study, we successfully developed a novel multiple stepwise SDP technique to develop aggregates of uniformly sized poly(methyl acrylates)-coated chitosan-diclofenac sodium nanocores (CS-PMA NPs) for colonic drug delivery. The processing conditions were optimized using the Box-Behnken design. SEM and TEM micrographs showed the optimized system to consist of 10 μm-sized agglomerates of CS-PMA NPs, the latter measuring 10 nm in diameter. High drug entrapment of 88% was attained. Potential colon-targeted drug release from the CS-PMA NPs was demonstrated, with retardation of drug release in simulated gastrointestinal fluids and over 90% of the drug load released into simulated colonic fluid within 8 h. Drug uptake from CS-PMA NPs into Caco-2 cells was threefold higher than that from a control drug solution, with no apparent cytotoxicity observed at the NP doses administered. The collective data suggest that the SDP is a robust manufacturing method that can potentially be used to scale up the production of composite nanoparticulate colon-targeted drug delivery systems.
机译:通过纺丝盘处理(SDP)技术的制药纳米粒子在其可扩展性和其产生易调谐纳米颗粒的窄尺寸分布的能力方面具有优点。在这项研究中,我们成功开发了一种新型多个逐步SDP技术,以开发均匀大小的聚(甲基丙烯酸甲酯)涂覆的壳聚糖 - 双氯芬酸钠纳米钠(CS-PMA NPS)的聚集体进行结肠药物递送。使用Box-Behnken设计进行了优化了处理条件。 SEM和TEM显微照片显示出优化的系统,包括10μm大小的CS-PMA NPS附聚物,后者的直径为10nm。达到了88%的高药物夹带。证明了来自CS-PMA NPS的潜在结肠靶向药物释放,在模拟的胃肠液中延迟药物释放,并且超过90%的药物负荷在8小时内释放到模拟结肠流体中。从CS-PMA NPS进入Caco-2细胞的药物吸收比从对照药物溶液的高度高,在施用NP剂量时没有观察到表观细胞毒性。集体数据表明,SDP是一种稳健的制造方法,可以用于扩大复合纳米颗粒靶向药物输送系统的生产。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号